Clinical Trial

Exparel vs. Marcaine ESP Block for Post-cardiac Surgical Pain

Enrolling by Invitation Phase 2/3
View on ClinicalTrials.gov →
Summary
The goal of this pilot study is to describe and compare Ultrasound-Guided Erector Spinae Plane (ESP) Blocks using Exparel® (bupivacaine liposome injectable suspension) to Marcaine® (bupivacaine hydrochloride) for pain management and outcomes after cardiac surgeries.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2023-10-04; most recent amendment 2026-02-12.
Status change: Recruiting → Enrolling by Invitation 2026-02-12
Status change: Not Yet Recruiting → Recruiting 2024-01-24
Trial Details
NCT Number NCT06077422
Lead Sponsor Rutgers, The State University of New Jersey
Collaborators: Pacira Pharmaceuticals, Inc
Conditions Pain, Postoperative, Opioid Use, Perioperative Complication, Heart Diseases
Enrollment 150 participants
Start Date 2024-01-11
Primary Completion 2027-01-11 (estimated)
Study Completion 2027-04-05 (estimated)
Updated on ClinicalTrials.gov 2026-02-17